Anthony Mega
Papers
2
Total Citations
41
H-Index
2
About
Anthony Mega is a urologic surgeon and researcher whose work centers on optimizing surgical outcomes for kidney and prostate cancers. His most influential contribution is a landmark 2017 study comparing open versus minimally invasive partial nephrectomy, which leveraged the National Surgical Quality Improvement Program to analyze perioperative morbidity. With 37 citations, this work provided crucial contemporary evidence that minimally invasive approaches reduce complications, helping to shift clinical practice toward robotic-assisted techniques. Mega also explored novel therapeutic strategies for high-risk prostate cancer, leading a Phase I/II clinical trial investigating neoadjuvant weekly ixabepilone. Though less cited, this study addressed the critical challenge of tumor downstaging and micrometastatic disease treatment, building on prior work with docetaxel. By combining rigorous outcomes research with early-phase drug development, Mega has advanced both the surgical and medical management of urologic malignancies. His work is particularly valuable for clinicians seeking evidence-based guidance on adopting minimally invasive surgery and for researchers pursuing neoadjuvant therapies to improve high-risk prostate cancer outcomes.
Research Focus
Key Achievements
Top Papers
- 1
- 2